Scottsdale, AZNCT06385236Now EnrollingIRB Ready

Severe Asthma Clinical Trial in Scottsdale, AZ

Access cutting-edge severe asthma treatment through this phase 4 clinical trial at a research site in Scottsdale. Study-provided care at no cost to qualified participants.

Sponsored by University of California, San Diego

Quick Self-Assessment

See if you qualify for this Scottsdale location

Preparing your pre-screening questions…

Expert Care in Scottsdale

Access severe asthma specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related severe asthma treatment provided free

Apply for This Scottsdale Location

Check if you qualify for this severe asthma clinical trial in Scottsdale, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Scottsdale

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Scottsdale site if eligible
  4. 4Begin participation

About This Severe Asthma Study in Scottsdale

In this study, a new method will be used to evaluate response to 2 approved biologic therapies, and assess how well each patient responds to each asthma treatment. This study will measure the response to these treatments using genomic and biologic measurements obtained from participants biosamples. By evaluating response to 2 different biologic therapies, this study has the potential to provide an in-depth understanding of the mechanisms underlying severe asthma that will inform and change trea

Sponsor: University of California, San Diego

Who Can Participate

Inclusion Criteria

Stated willingness to comply with all study procedures and availability for the duration of the study.
Stable asthma medications: No change in asthma medications for the past 2 months:
Use of medium or high dose inhaled corticosteroids (ICS) AND
Use of an additional asthma controller medication.
Baseline poor or uncontrolled asthma.
Evidence of asthma demonstrated by either bronchodilator reversibility (either at screening or by historical evidence) or methacholine responsiveness (by historical evidence).
Agreement to adhere to Lifestyle Considerations throughout study duration.

Exclusion Criteria

Current participation in an interventional trial (e.g. drugs, diets, etc.).
Currently on an asthma biologic or having been on biologic within 3 months of screening.
Enrollment in a clinical trial where the study medication was administered within the past 60 days or within 5 half-lives (whichever is greater).
Physician diagnosis of other chronic pulmonary disorders associated with asthma-like symptoms, including, but not limited to, cystic fibrosis (CF), chronic obstructive pulmonary disease (COPD), chronic bronchitis, emphysema, severe scoliosis or chest wall deformities that affect lung function, or congenital disorders of the lungs or airways.
Receiving one or more immune-modulating therapies for diseases other than asthma. This includes biologics that are also approved for asthma.
Receiving methotrexate, mycophenolate (CellCept®), or azathioprine (Imuran®).
Receiving aero allergen immunotherapy and not on at least 3 months of maintenance allergen immunotherapy.
Underwent a bronchial thermoplasty within the last two years.
Born before 30 weeks of gestation.
Uncontrolled hypertension, defined as systolic blood pressure \> 160 mm/Hg or diastolic blood pressure \> 100 mm/Hg.
History of malignancy except non-melanoma skin cancer within the last five years.
History of smoking:
If \<45 years old: Smoked for ≥5 pack-years\
If ≥45 years old: Smoked ≥ 10 pack years.
Active use of any inhalant \>1 time per month in the past year.
Substance abuse within the last year.
Unwillingness to practice medically acceptable birth control or complete abstinence during the study, current pregnancy, or lactation.
Requirement for daily systemic corticosteroids at the time of screening.
Respiratory infection within 1 month of screening.
Intubation for asthma in the last 12 months.
Any clinically significant abnormal findings in the history, physical examination, vital signs, electrocardiogram, hematology or clinical chemistry during run-in period, which in the opinion of the site investigator, may put the participant at risk because of his/her participation in the study, or may influence the results of the study, or the participant's ability to complete the entire duration of the study.
Allergic to any of the drugs, biologics or chemicals used in this study.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Scottsdale?

Yes, this clinical trial (NCT06385236) has an active research site in Scottsdale, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Severe Asthma Treatment Options in Scottsdale, AZ

If you're searching for severe asthma treatment options in Scottsdale, AZ, this clinical trial (NCT06385236) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Scottsdale research site is actively enrolling participants for this phase 4 clinical trial. You'll receive care from experienced severe asthma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all severe asthma clinical trials near you to find additional studies recruiting in your area.

More Ankylosing Spondylitis Trials in Scottsdale, AZ

See all ankylosing spondylitis clinical trials recruiting in Scottsdale — not just this study.

Browse Ankylosing Spondylitis Trials in Scottsdale →

Browse More Trials by Condition

Ankylosing Spondylitis TrialsAsthma TrialsModerate-to-Severe Asthma TrialsAll Conditions →

Ready to Join in Scottsdale?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Scottsdale, AZ